Walvax (SHE: 300142) recently formed a strategic collaboration with Honeywell (Nasdaq: HON) that led to the construction of China’s first mRNA COVID-19 vaccine production plant. The company has been working since 2017 to become a leading vaccine R&D company, recounted Shawn Opatka, vice president, life sciences, Honeywell Process Solutions. “Their goals accelerated the construction of…